These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9504433)

  • 1. Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite albendazole sulphoxide.
    Jung H; Medina L; García L; Fuentes I; Moreno-Esparza R
    J Pharm Pharmacol; 1998 Jan; 50(1):43-8. PubMed ID: 9504433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability comparison between albendazole and albendazole sulphoxide in rats and man.
    Dominguez L; Fagiolino P; Gordon S; Manta E
    Farmaco; 1995 Oct; 50(10):697-702. PubMed ID: 8590577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipidic matrix of albendazole sulphoxide: is it an alternative for systemic infections?
    Domínguez L; Savio E; Saldaña J; Malanga A; Quevedo D; Camarote C; Ochoa A; Fagiolino P
    Boll Chim Farm; 1998 Nov; 137(10):383-6. PubMed ID: 9880943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Properties of Albendazole Desmotropes by Supramolecular Systems with Maltodextrin and Glutamic Acid.
    Bongioanni A; Araújo BS; de Oliveira YS; Longhi MR; Ayala A; Garnero C
    AAPS PharmSciTech; 2018 Apr; 19(3):1468-1476. PubMed ID: 29464593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined in vitro in-silico approach to predict the oral bioavailability of borderline BCS Class II/IV weak base albendazole and its main metabolite albendazole sulfoxide.
    Pettarin M; Bolger MB; Chronowska M; Kostewicz ES
    Eur J Pharm Sci; 2020 Dec; 155():105552. PubMed ID: 32937212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent systemic exposure of albendazole metabolites in lambs.
    Alvarez L; Suárez G; Ceballos L; Moreno L; Lanusse C
    J Vet Pharmacol Ther; 2012 Aug; 35(4):365-72. PubMed ID: 21819410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transport of albendazole and albendazole sulphoxide in the lancet fluke (Dicrocoelium dendriticum).
    Bártíková H; Vokřál I; Forstová-Křížová V; Skálová L; Lamka J; Szotáková B
    Vet Parasitol; 2011 Feb; 176(1):27-33. PubMed ID: 21075525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.
    Shinde RL; Bharkad GP; Devarajan PV
    Eur J Pharm Biopharm; 2015 Oct; 96():363-79. PubMed ID: 26318978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption and metabolism of albendazole after intestinal ischemia/reperfusion.
    Molina AJ; Merino G; Prieto JG; Real R; Mendoza G; Alvarez AI
    Eur J Pharm Sci; 2007 May; 31(1):16-24. PubMed ID: 17350811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of albendazole and albendazole sulphoxide by ruminal and intestinal fluids of sheep and cattle.
    Lanusse CE; Nare B; Gascon LH; Prichard RK
    Xenobiotica; 1992 Apr; 22(4):419-26. PubMed ID: 1523862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantioselective binding of albendazole sulphoxide to cytosolic proteins from helminth parasites.
    Solana HD; Sallovitz JM; Lanusse CE; Rodriguez JA
    Methods Find Exp Clin Pharmacol; 2002; 24(1):7-13. PubMed ID: 11980387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time dependent pharmacokinetics of albendazole in human.
    Mirfazaelian A; Rouini MR; Dadashzadeh S
    Biopharm Drug Dispos; 2003 Jul; 24(5):199-204. PubMed ID: 12784319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma disposition and faecal excretion of netobimin metabolites and enantiospecific disposition of albendazole sulphoxide produced in ewes.
    Gokbulut C; Cirak VY; Senlik B
    Vet Res Commun; 2006 Oct; 30(7):791-805. PubMed ID: 17004041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of thermophilic fungus Rhizomucor pusillus NRRL 28626 in biotransformation of antihelmintic drug albendazole.
    Prasad GS; Girisham S; Reddy SM
    Appl Biochem Biotechnol; 2011 Nov; 165(5-6):1120-8. PubMed ID: 21837380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of albendazole sulphoxide into hydatid cysts.
    Morris DL; Chinnery JB; Georgiou G; Stamatakis G; Golematis B
    Gut; 1987 Jan; 28(1):75-80. PubMed ID: 3817589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the efficacy of albendazole sulphoxide and praziquantel in combination on Taenia crassiceps cysts: in vitro studies.
    Palomares F; Palencia G; Ambrosio JR; Ortiz A; Jung-Cook H
    J Antimicrob Chemother; 2006 Mar; 57(3):482-8. PubMed ID: 16410266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of clotrimazole on microsomal metabolism and pharmacokinetics of albendazole.
    Merino G; Molina AJ; García JL; Pulido MM; Prieto JG; Alvarez AI
    J Pharm Pharmacol; 2003 Jun; 55(6):757-64. PubMed ID: 12841935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
    Kataoka M; Fukahori M; Ikemura A; Kubota A; Higashino H; Sakuma S; Yamashita S
    Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis.
    Takayanagui OM; Bonato PS; Dreossi SA; Lanchote VL
    Br J Clin Pharmacol; 2002 Aug; 54(2):125-30. PubMed ID: 12207631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs.
    Daniel-Mwambete K; Torrado S; Cuesta-Bandera C; Ponce-Gordo F; Torrado JJ
    Int J Pharm; 2004 Mar; 272(1-2):29-36. PubMed ID: 15019066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.